The claimEvidence against it: moderate (meta-analyses of mixed quality)
Curcumin cures any kind of inflammation
The evidence
It holds down inflammatory pathways in cells, but in people it rarely reaches that concentration; small trials back it for knee osteoarthritis pain, lipids showed no effect, and cancer prevention and anti-aging have almost no human evidence.
Why the claim spreads
Curcumin really does hold down inflammatory pathways in cells, and many diseases are linked to inflammation; the single word anti-inflammatory is easily read as a cure for all of them.
The mechanism, in brief
Curcumin can hold down inflammatory pathways in cells, but that does not mean it treats every disease linked to inflammation. The human evidence differs sharply from condition to condition. For knee osteoarthritis pain, a set of small randomized trials points the same way. For depression there are only a few small…
Sources (3)
- Daily, J. W., Yang, M., & Park, S. (2016). Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. Journal of Medicinal Food, 19(8), 717–729.
- Lopresti, A. L., et al. (2014). Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167, 368–375.
- Lopresti, A. L., & Drummond, P. D. (2017). Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: a randomised, double-blind, placebo-controlled study. Journal of Affective Disorders, 207, 188-196.
Related debunks
- Milk thistle pills protect the liver, lower enzymes, and repair liver damageEvidence against it: high (guidelines or large endpoint trials)
- My transaminases came down, so my liver has healedEvidence against it: moderate (meta-analyses of mixed quality)
- Take a liver pill before drinking and your liver is coveredEvidence against it: high (guidelines or large endpoint trials)
- Aspirin 60+ for primary cardiovascular preventionEvidence against it: high (guidelines or large endpoint trials)